Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
(2008) In European Journal of Cardiovascular Prevention & Rehabilitation 15(3). p.258-262- Abstract
- BACKGROUND: To evaluate potential sex differences, this study aimed to investigate blood pressure and lipid control and other risk factors for cardiovascular disease in treated hypertensive (tHT) patients from primary healthcare. DESIGN AND METHODS: This cross-sectional survey of tHT patients was carried out between 2002 and 2005 by 264 primary care physicians from Sweden who consecutively recruited 6537 tHT patients (48% men and 52% women) from medical records. RESULTS: tHT men more often reached the treatment goal for systolic/diastolic blood pressure, less than 140/90 mmHg, than tHT women (30 vs. 26%, P<0.01). Men had lower systolic blood pressure than women, however, women had lower diastolic blood pressure and higher pulse... (More)
- BACKGROUND: To evaluate potential sex differences, this study aimed to investigate blood pressure and lipid control and other risk factors for cardiovascular disease in treated hypertensive (tHT) patients from primary healthcare. DESIGN AND METHODS: This cross-sectional survey of tHT patients was carried out between 2002 and 2005 by 264 primary care physicians from Sweden who consecutively recruited 6537 tHT patients (48% men and 52% women) from medical records. RESULTS: tHT men more often reached the treatment goal for systolic/diastolic blood pressure, less than 140/90 mmHg, than tHT women (30 vs. 26%, P<0.01). Men had lower systolic blood pressure than women, however, women had lower diastolic blood pressure and higher pulse pressure. More tHT women had total cholesterol >/=5.0 mmol/l than corresponding men (75 vs. 64% P<0.001). Men more often had diabetes (25 vs. 20% P<0.001), left ventricular hypertrophy (20 vs. 16% P<0.001), and microalbuminuria (24 vs. 16% P<0.001). Women were more often treated with diuretics (64 vs. 48%) and beta-receptor blockers (54 vs. 51%), and men more often treated with angiotensin-converting enzyme inhibitors (27 vs. 18%), calcium channel blockers (34 vs. 26%), and lipid-lowering drugs (34 vs. 29%). CONCLUSION: A need still exists for more intensified treatment of elevated blood pressure and hypercholesterolemia, especially in women. In hypertensives of both sexes, smoking and other risk factors also need to be addressed to reduce the risk of cardiovascular disease. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1169169
- author
- Journath, Gunilla ; Hellénius, Mai-Lis ; Petersson, Ulla LU ; Theobald, Holger and Nilsson, Peter LU
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Journal of Cardiovascular Prevention & Rehabilitation
- volume
- 15
- issue
- 3
- pages
- 258 - 262
- publisher
- Lippincott Williams & Wilkins
- external identifiers
-
- wos:000257185200003
- pmid:18525379
- scopus:56149112987
- pmid:18525379
- ISSN
- 1741-8275
- DOI
- 10.1097/HJR.0b013e3282f37a45
- language
- English
- LU publication?
- yes
- id
- 79d6519c-e3a8-4aa0-a340-573ca3dfc304 (old id 1169169)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/18525379?dopt=Abstract
- date added to LUP
- 2016-04-04 08:18:39
- date last changed
- 2022-02-05 23:49:12
@article{79d6519c-e3a8-4aa0-a340-573ca3dfc304,
abstract = {{BACKGROUND: To evaluate potential sex differences, this study aimed to investigate blood pressure and lipid control and other risk factors for cardiovascular disease in treated hypertensive (tHT) patients from primary healthcare. DESIGN AND METHODS: This cross-sectional survey of tHT patients was carried out between 2002 and 2005 by 264 primary care physicians from Sweden who consecutively recruited 6537 tHT patients (48% men and 52% women) from medical records. RESULTS: tHT men more often reached the treatment goal for systolic/diastolic blood pressure, less than 140/90 mmHg, than tHT women (30 vs. 26%, P<0.01). Men had lower systolic blood pressure than women, however, women had lower diastolic blood pressure and higher pulse pressure. More tHT women had total cholesterol >/=5.0 mmol/l than corresponding men (75 vs. 64% P<0.001). Men more often had diabetes (25 vs. 20% P<0.001), left ventricular hypertrophy (20 vs. 16% P<0.001), and microalbuminuria (24 vs. 16% P<0.001). Women were more often treated with diuretics (64 vs. 48%) and beta-receptor blockers (54 vs. 51%), and men more often treated with angiotensin-converting enzyme inhibitors (27 vs. 18%), calcium channel blockers (34 vs. 26%), and lipid-lowering drugs (34 vs. 29%). CONCLUSION: A need still exists for more intensified treatment of elevated blood pressure and hypercholesterolemia, especially in women. In hypertensives of both sexes, smoking and other risk factors also need to be addressed to reduce the risk of cardiovascular disease.}},
author = {{Journath, Gunilla and Hellénius, Mai-Lis and Petersson, Ulla and Theobald, Holger and Nilsson, Peter}},
issn = {{1741-8275}},
language = {{eng}},
number = {{3}},
pages = {{258--262}},
publisher = {{Lippincott Williams & Wilkins}},
series = {{European Journal of Cardiovascular Prevention & Rehabilitation}},
title = {{Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.}},
url = {{http://dx.doi.org/10.1097/HJR.0b013e3282f37a45}},
doi = {{10.1097/HJR.0b013e3282f37a45}},
volume = {{15}},
year = {{2008}},
}